43rd Annual National Jewish Health Pulmonary and Allergy Update (Online)

43rd Annual National Jewish Health Pulmonary and Allergy Update (Online)
For more information, please contact:
The Office of Professional Education
at National Jewish Health
303.398.1000
800.844.2305

Register below to access the recorded virtual sessions and earn CME/CE credit.  These recordings will be available until December 31, 2021. Payment is required to access the content.

For more information or if you have questions, please contact The Office of Professional Education at National Jewish Health at  ProEd@NJHealth.org.


 

Purpose

The National Jewish Health Pulmonary and Allergy Update (formerly taking place at Keystone, Colorado) will be held online this year. This new format will continue to provide insights and recent advances in pulmonary medicine, asthma, allergy and immunology, presented by faculty from the *leading respiratory hospital in the nation. 

Learn the latest updates on management and treatment options for the diseases National Jewish Health treats and researches. Workshop sessions also provide great opportunities to hear about key issues and interesting cases with colleagues and National Jewish Health faculty.

Download the Lecture and Workshop program agenda (PDF). Registered attendees will have access to the recorded sessions until December 31, 2021.
 

Sponsors and Exhibitors

 

Program Chairs:


Harold Nelson, MD
Professor
Department of Medicine
Division of Allergy and Clinical Immunology
National Jewish Health, Denver, CO

 

Eileen Wang, MD, MPH
Assistant Professor
Division of Allergy & Clinical Immunology
Department of Medicine 
National Jewish Health, Denver, CO
 

Michael Wechsler, MD
Director of The Cohen Family Asthma Institute
Professor of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health, Denver, CO
   

Pamela L. Zeitlin, MD, PhD
Silverstein Chair, Department of Pediatrics
Professor of Pediatrics
National Jewish Health, Denver, CO

 

 

Who Should Register

Allergists, Pulmonologists, Primary Care and Internal Medicine Physicians, Pediatricians, Physician Assistants, Advanced Practice Nurses, Registered Nurses and others working with adults and children with allergic and pulmonary disease.


*National Jewish Health has a 121-year history as the leading respiratory hospital in the nation and is the only hospital devoted fully to the treatment of respiratory and related illnesses.

2021 Agenda

The live event took place online on February 4-5, 2021, and followed this agenda. All educational sessions and workshops are now available online through December 31, 2021. Please register to view and earn CME/CNE credit.
 

THURSDAY, FEBRUARY 4, 2021
4:15  p.m. Welcome and Overview
   
Educational Sessions  
4:30 – 5:00 p.m. Asthma Update 2021: New Guidelines and Emerging Therapies 
(10 minutes Q&A) Michael Wechsler, MD
   
5:10 – 5:40 p.m. Is Marijuana Use and Vaping Safe Compared to Smoking Tobacco?
(10 minutes Q&A) Russell Bowler, MD, PhD
   
5:50 – 6:20 p.m. COVID-19 Overview and Management
(10 minutes Q&A) Shannon Kasperbauer, MD
   
6:30 – 6:45 p.m. EXHIBITS
   
Concurrent Workshops
6:45 – 7:30 p.m. #1 - Marijuana and Vaping Cases
  Russell Bowler, MD, PhD
   
  #2 - Asthma Cases (Pulmonologist and Allergist Perspective)
  Vamsi Guntur, MD, MSc and Eileen Wang, MD, MPH
   
   
FRIDAY, FEBRUARY 5, 2021
7:30 – 8:00 a.m. EXHIBITS
   
Educational Sessions
8:00 – 8:30 a.m. Atopic Dermatitis Treatment: What’s New and What’s Coming
(10 minutes Q&A) Mark Boguniewicz, MD
   
8:40 – 9:10 a.m.    Hindsight is 2020: Progress in Food Allergy During the Pandemic 
(10 minutes Q&A) Bruce J. Lanser, MD, MPH
   
9:20 – 9:50 a.m. COVID-19 Vaccine Update
(10 minutes Q&A) Anuj Mehta, MD
   
10:00 – 10:15 a.m. EXHIBITS
   
Concurrent Workshops  
10:15 – 11:00 a.m. #1 - Food Allergy and Atopic Dermatitis Discussion and Cases    
  BJ Lanser, MD, MPH and Mark Boguniewicz, MD
   
  #2 - Allergy Immunotherapy: The Recent Literature
  Harold Nelson, MD
   
11:00 – 11:15 a.m. EXHIBITS
   
11:15 a.m. – 12:00 p.m. Non-CME/CE Session * 
  Sounding the Alarm: The Role of TSLP Across the Spectrum of Asthma Inflammation - Sponsored by Amgen/AstraZeneca
  Michael Wechsler, MD
  *This session is not part of the official 43rd Annual National Jewish Health Pulmonary and Allergy Update as planned by the program chairs. 
   
Educational Sessions
12:00 – 12:30 p.m. Expanding the Definition of COPD
(10 minutes Q&A) Barry Make, MD 
   
12:40 – 1:10 p.m. Progressive Pulmonary Fibrosis
(10 minutes Q&A) Amy Olson, MD, MSPH
   
1:20 – 1:50 p.m. Recovery Post Acute Covid19 and the "Long Haul"
(10 minutes Q&A) Nir Goldstein, MD
   
2:00 – 2:15 p.m. BREAK/EXHIBITS
   
Workshop  
2:15 – 3:00 p.m. COVID-19 Cases and Questions
  Nir Goldstein, MD, Shannon Kasperbauer, MD, and  Anuj Mehta, MD
   
3:00 p.m. Closing Comments

Download the Lecture and Workshop program agenda (PDF).

Registration Fees:

$99 – MDs, DOs and Industry Partners
$79 – NPs, PAs, RNs, RPhs and other Allied Health Professionals
$29 – National Jewish Health Staff


Register here to access the recorded virtual sessions and earn CME/CE credit.  These recordings will be available until December 31, 2021. Payment is required to access the content.

For more information or if you have questions, please contact The Office of Professional Education at National Jewish Health at proed@njhealth.org.



* Indicates required field

Contact Information

Additional Information

Fees



$0.00

For other payment arrangements, please contact ProEd@njhealth.org.

View a list of our Sponsors and Exhibitors here:

Sponsors and Exhibitors

 


Exhibitor Information

Platform:  Zoom
Context:  Zoom breakout rooms as virtual exhibit booths

Exhibit Times:
Thursday, February 4

6:30 pm – 6:45 pm (MST)

Friday, February 5
7:30 – 8:00 am (MST)
10:00 am – 10:15 am (MST)
11:00 am – 11:15 am (MST)   
2:00 pm – 2:15 pm (MST)

Exhibitors will have access to their virtual exhibit booth (in Zoom breakout rooms) during the conference on February 4 and 5. Attendees can navigate to your breakout room/virtual booth when they are not in the main conference presentation (see the schedule above for designated exhibit times). In your virtual booth, your team can share your screen to present slides, webpages, or you can feed a pre-recorded video loop into your camera channel.  

Your team can have access to several Zoom breakout rooms, such that you can have one virtual booth as a group presentation, and other breakout rooms for live one-on-one discussions. Alternatively, if you prefer to remain in one virtual booth, one or more of your team members can use the chat feature to engage one-on-one, while another team member presents to the group of attendees in your booth. 

You can provide links and PDFs to attendees via the chat feature in Zoom. Attendees who enter your booth after you’ve shared a link or file in the chat will not see previous items, so you can assure they have access by posting for each attendee who enters. 

You may also use QR codes in your screen share so that attendees can use the camera on their phone or tablet to quickly get the contact info/links to follow up after the conference.

EXHIBITOR & SPONSORSHIP WEBPAGE

Along with the virtual booths via Zoom, exhibitors and sponsors will have the opportunity to highlight their organizations and products on the Exhibitor and Sponsorship section of the Pulmonary and Allergy Update website through a brief company description and the ability to link to PDFs, videos, or other materials. Placement of company logos and information will be based on exhibit and sponsorship levels. 

Please forward your company logo, brief company and product description, any PDF’s you would like us to link to, links to videos or other websites that you would like us to direct conference attendees. Assets should be submitted by January 25th but the sooner you send them the sooner we can get them up and visible to visitors to the conference website. 

Please email proed@njhealth.org with any questions. 
 


EXHIBITOR POLICY AGREEMENT

  • The primary purpose of the activity is education of physicians
  • The activity is free of commercial bias for or against any product
  • Content and materials give a balanced view of therapeutic options
  • As the sponsor, National Jewish Health designs, plans and oversees the educational content
  • Conference participants will be made aware of any significant financial relationship between

PAYMENT TERMS AND CONDITIONS
Full payment should be received no later than February 1, 2021. You can pay by check or credit card. If paying by credit card please email Mandy at ComeauM@njhealth.org and she will call you to coordinate payment.

Accreditation and Designation Statements

Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this enduring material for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registered Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724, for 7.75 contact hours.

 

Continuing Medical Education Disclaimer

National Jewish Health ("NJH") and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, "NJH Parties") shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

 

Faculty and Planner Disclosures

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and medical writers in a position to control the content of this activity are expected to disclose any relevant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

Relevant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., Stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

All CME Educational Activities sponsored by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.


Faculty Disclosures

Mark Boguniewicz, MD declares that he is on an Advisory Board for Leo Pharma and Pfizer as well as is a consultant for Abbvie. He also is an investigator for Incyte and receives honoraria from Abbvie, Leo Pharma and Pfizer.

Russell Bowler, MD, PhD declares that he does not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks.

Vamsi Guntur, MD, MSc declares that she does not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks.

Nir Goldstein, MD declares that he does not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks.

Shannon Kasperbauer, MD declares that she is on an advisory board for AN2Therapeutics and Insmed as well as an investigator and speaker for Insmed.  She is also a speaker for Paratek.

Bruce J. Lanser, MD declares that he is on an advisory board for Aimmune, Allergenis and Sanofi.  He is an investigator for Aimmune, DBV Technologies, NIH/NIAID and Regeneron as well as a speaker for Aimmune.

Barry Make, MD declares that he is on an advisory board for Astra Zeneca, Spiration, GlaxoSmithKline, Sunovion, Verona, Boehringer Ingelheim, Theravance, Circassia, Phillips, Science 24/7, Takeda.  He also has relevant financial intests with Pearl Research, Third Pole, NHLBI, Wolters Kluwer Health, Mt. Sinai, WebMD, Novartis, American College of Chest Physicians, Projects in Knowledge, Hybrid Communications, Medscape, Ultimate Medical Academy, Eastern Pulmonary Society, Catamount Medical, Eastern VA Medical Center, Academy of Continued Health Care Learning.

Anuj Mehta, MD declares that he does not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks.

Harold Nelson, MD declares that he does not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks.

Amy Olson, MD, MSPH declares that she does not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks.

Eileen Wang, MD, MPH declares that she is a consultant for AstraZeneca and Clinical Care Options as well as an investigator for Genentech, GlaxoSmithKline and OPC.

Michael Wechsler, MD declares that he is a consultant for Amgen, AstraZeneca, Boehringer Ingelheim, Cohero, Equilium, Genentech, GlaxoSmithKline, Novartis, Sanofi/Regeneron, Sentien and Teva.

Pamela Zeitlin, MD declares that she does not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks.


Planner/Reviewer Disclosures

Ronina Covar, MD declares that she is a consultant for Cohero Health and Sanofi as well as an investigator for GlaxoSmithKline.

Anthony Gerber, MD, PhD declares that he is a consultant for BeiGene, Biosciences Pharma and Pliant Therapeutics.

Eileen Wang, MD, MPH declares that she is a consultant for AstraZeneca and Clinical Care Options as w

Michael Wechsler, MD declares that he is a consultant for Amgen, AstraZeneca, Boehringer Ingelheim, Cohero, Equilium, Genentech, GlaxoSmithKline, Novartis, Sanofi/Regeneron, Sentien and Teva.

The following planners and reviewers declare that they do not have any relevant financial interests, arrangements, or affiliations with any commercial entity(ies) related to the presentation materials and/or talks:

Meghan Brenner, MA
Mandy Comeau
Andrea Harshman, MHA, CHCP, CMP-HC
Michael Mohning, MD
Harold Nelson, MD
Hillary Scanlan, RN
Amen Sergew, MD
Pamela Zeitlin, MD

Sponsors and Exhibitors


View the list of Sponsors and Exhibitors who are supporting the 43rd Annual National Jewish Health Pulmonary and Allergy Update.